SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

29 Oct 2021 Evaluate
The revenue zoomed 15.98% to Rs. 1126.50 millions for the quarter ended September 2021 as compared to Rs. 971.30 millions during the corresponding quarter last year.The company has announced a 41.26% increase in its profits to Rs . 157.50  millions for the  quarter ended September 2021 compared to Rs. 111.50 millions in the corresponding quarter in the previous year.The company reported a good operating profit of 265.10 millions compared to 191.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1126.50 971.30 15.98 2207.80 1887.80 16.95 3891.40 3755.70 3.61
Other Income 7.10 0.40 1675.00 11.20 4.90 128.57 9.10 7.30 24.66
PBIDT 265.10 191.60 38.36 498.70 364.60 36.78 708.40 598.80 18.30
Interest 1.70 2.30 -26.09 3.00 5.40 -44.44 7.90 17.50 -54.86
PBDT 263.40 189.30 39.14 495.70 359.20 38.00 700.50 528.10 32.65
Depreciation 39.90 42.00 -5.00 79.50 83.60 -4.90 164.70 163.60 0.67
PBT 223.50 147.30 51.73 416.20 275.60 51.02 535.80 364.50 47.00
TAX 66.00 35.80 84.36 122.90 73.50 67.21 135.80 74.40 82.53
Deferred Tax -1.00 -11.50 -91.30 -1.90 -14.90 -87.25 -35.70 -26.60 34.21
PAT 157.50 111.50 41.26 293.30 202.10 45.13 400.00 290.10 37.88
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.53 19.73 19.30 22.59 19.31 16.95 18.20 15.94 14.18

RPG Life Sciences Share Price

2025.85 126.05 (6.63%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×